FMR LLC 13D and 13G filings for Prelude Therapeutics Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-10 08:53 am Sale | 2024-01-09 | 13G | Prelude Therapeutics Incorporated PRLD | FMR LLC | 264,686 0.630% | -4,613,865 (-94.57%) | Filing |
| 2023-02-10 09:08 am Purchase | 2023-02-09 | 13G | Prelude Therapeutics Incorporated PRLD | FMR LLC | 4,878,551 10.193% | 288,960 (+6.30%) | Filing |
| 2023-02-09 12:31 pm Sale | 2023-02-09 | 13G | Prelude Therapeutics Incorporated PRLD | FMR LLC | 4,589,591 9.589% | -1,349,341 (-22.72%) | Filing |
| 2022-02-09 10:24 am Sale | 2022-02-08 | 13G | Prelude Therapeutics Incorporated PRLD | FMR LLC | 5,938,932 12.578% | -413,049 (-6.50%) | Filing |
| 2021-02-10 09:23 am Purchase | 2021-02-09 | 13G | Prelude Therapeutics Incorporated PRLD | FMR LLC | 6,351,981 13.747% | 2,142,018 (+50.88%) | Filing |
| 2021-02-08 10:31 am Purchase | 2021-02-05 | 13G | Prelude Therapeutics Incorporated PRLD | FMR LLC | 4,209,963 9.633% | 4,209,963 (New Position) | Filing |